DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) had its price objective lowered by JPMorgan Chase & Co. from $12.00 to $10.00 in a report published on Friday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical instruments supplier’s stock.
A number of other equities analysts have also recently weighed in on the stock. Barclays lifted their price target on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. Piper Sandler lowered their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a research report on Friday, October 9th. Leerink Partners dropped their price objective on DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating on the stock in a research note on Wednesday, October 14th. Barrington Research reduced their target price on DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 26th. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a report on Friday, October 30th. Three analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus target price of $12.42.
Check Out Our Latest Report on XRAY
DENTSPLY SIRONA Price Performance
DENTSPLY SIRONA stock opened at $9.46 on Friday. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of -15.26, a PEG ratio of 1.27 and a beta of 0.87. The company’s 50 day simple moving average is $9.60 and its 200 day simple moving average is $11.28. The company has a debt-to-equity ratio of 1.47, a current ratio of 1.63 and a quick ratio of 1.04. DENTSPLY SIRONA has a fifty-two week low of $8.14 and a fifty-two week high of $14.76.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last issued its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.02). DENTSPLY SIRONA had a negative net margin of 3.38% and a positive return on equity of 20.21%. The firm had revenue of $836.00 million during the quarter, compared to the consensus estimate of $861.68 million. During the same period in the previous year, the company posted $0.37 EPS. The firm’s revenue for the quarter was down 7.5% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. As a group, sell-side analysts anticipate that DENTSPLY SIRONA will post 1.33 EPS for the current year.
Institutional Trading of DENTSPLY SIRONA
Several hedge funds have recently bought and sold shares of the stock. AlphaCore Capital LLC raised its stake in shares of DENTSPLY SIRONA by 9.9% in the 3rd quarter. AlphaCore Capital LLC now owns 14,386 shares of the medical instruments supplier’s stock valued at $127,000 after purchasing an additional 1,298 shares during the period. Oregon Public Employees Retirement Fund lifted its holdings in shares of DENTSPLY SIRONA by 3.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 40,944 shares of the medical instruments supplier’s stock valued at $475,000 after purchasing an additional 1,300 shares in the last quarter. Bfsg LLC lifted its holdings in shares of DENTSPLY SIRONA by 13.4% in the third quarter. Bfsg LLC now owns 22,230 shares of the medical instruments supplier’s stock valued at $197,000 after purchasing an additional 2,620 shares in the last quarter. Brighton Jones LLC boosted its position in shares of DENTSPLY SIRONA by 7.6% during the third quarter. Brighton Jones LLC now owns 37,673 shares of the medical instruments supplier’s stock worth $334,000 after buying an additional 2,668 shares during the period. Finally, Allworth Financial LP boosted its position in shares of DENTSPLY SIRONA by 163.8% during the second quarter. Allworth Financial LP now owns 4,815 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 2,990 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.
About DENTSPLY SIRONA
DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.
Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
